Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Rise of Mid-Sized Pharma
2.
Contract Research Annual Review 2008
3.
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
4.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
5.
Monoclonal Antibodies Report: 2008 Update
6.
Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
7.
Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
8.
Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
9.
Drug Repositioning Strategies - Serendipity by design
10.
Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Immunogenicity to Biologics Implications of reactions against biotech drugs
3.
Neuro Stents & Coils Technology and Market Forecast
4.
Outsourcing in Drug Discovery, 3rd Edition
5.
American Hospital Register
6.
Professional Designation in Biopharmaceutical Technology - 3 Course Curriculum
7.
Outlook for RNAi, 2007 - siRNA and miRNA in biology, diagnostics and therapeutics
Partneringdesk Deals and Alliances therapy report
Partneringdesk Deals and Alliances therapy reports
Partneringdesk Deals and Alliances therapy reports provide a comprehensive summary of the deals and alliances announced in the therapeutic area in the last five years, in a clear and accessible printable format.
Every deal entry includes financial information where disclosed, such as headline values and upfront payments.
The Partneringdesk Deals and Alliances therapy reports series includes fourteen therapy areas, each covering the five years to the release date, and are updated every six months.
1. Oncology
2. Infectious diseases
3. Cardiovascular diseases
4. Central nervous system diseases
5. Autoimmune/inflammatory diseases
6. Metabolic diseases
7. Respiratory diseases
8. Gastrointestinal diseases
9. Musculoskeletal diseases
10. Sensory and dental diseases
11. Genitourinary and gynecological diseases
12. Dermatological diseases
13. Blood and lymphatic diseases
14. Hospital, accident and trauma
Introduction
A summary of the deals and dealmakers in the therapy area over a five-year period. Includes charts and tables summarising activity in the therapy area.
Chapter 1: Deals by company
A comprehensive overview listing deals by company, with a full index of all the deals announced. A clear and easy way to see the activities of any company.
Chapter 2: Stage of development
A review of deals by stage of development. Appreciate how deal values change from discovery to launch in the therapy area.
Chapter 3: Top 25 Company profiles
Summary profiles for the most active companies in the therapy area over the past five years, including history, business strategy, partnering strategy, and deals listing.
Chapter 4: Detailed listing of deals and alliances
A full index of all the deals announced in the covered period. Entries contain financial information such as headline value, upfront and royalty rates, where available.
Each Deals and Alliances therapy report costs $2,495 and is delivered as a PDF.
Price
Oncology $2495.00
Infectious diseases $2495.00
Cardiovascular diseases $2495.00
Central nervous system diseases $2495.00
Autoimmune/inflammatory diseases $2495.00
Metabolic diseases $2495.00
Respiratory diseases $2495.00
Gastrointestinal diseases $2495.00
Musculoskeletal diseases $2495.00
Sensory and dental diseases $2495.00
Genitourinary and gynecological $2495.00
Dermatological diseases $2495.00
Blood and lymphatic diseases $2495.00
Hospital, accident and trauma $2495.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.